aCL from patients with APS (but not from non-APS patients) require β2GPI as a co-factor for CL-binding whilst the LA effect has been shown to be β2GPI-sensitive in these patients [[5], [6], [7]]. This evidence concerns the gene APOH and autoimmune polyendocrinopathy.